Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 5, Mai 2011
Page(s) 508 - 513
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2011275016
Publié en ligne 25 mai 2011
  1. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005 ; 24 : 2796-2809. [CrossRef] [PubMed] [Google Scholar]
  2. Dimova DK, Dyson NJ. The E2F transcriptional network : old acquaintances with new faces. Oncogene 2005 ; 24 : 2810-2826. [CrossRef] [PubMed] [Google Scholar]
  3. Harbour JW, Dean DC. The Rb/E2F pathway : expanding roles and emerging paradigms. Genes Dev 2000 ; 14 : 2393-2409. [Google Scholar]
  4. Bjorntorp P, Ostman J. Human adipose tissue dynamics and regulation. Adv Metab Disord 1971 ; 5 : 277-327. [PubMed] [Google Scholar]
  5. Fajas L. Adipogenesis : a cross-talk between cell proliferation and cell differentiation. Annals of Medicine 2003 ; 35 : 79-85. [CrossRef] [PubMed] [Google Scholar]
  6. Gervois P, Fruchart JC. PPAR gamma : a major nuclear receptor in adipogenesis. Med Sci (Paris) 2003 ; 19 : 20-22. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. Fajas L, Landsberg RL, Huss-Garcia Y, et al. E2Fs regulate adipocyte differentiation. Dev Cell 2002 ; 3 : 39-49. [CrossRef] [PubMed] [Google Scholar]
  8. Landsberg RL, Sero JE, Danielian PS, et al. The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity. Proc Natl Acad Sci USA 2003 ; 100 : 2456-2461. [CrossRef] [Google Scholar]
  9. Aguilar V, Fajas L. Cycling through metabolism. EMBO Mol Med 2010 ; 2 : 338-348. [CrossRef] [PubMed] [Google Scholar]
  10. Chen P, Riley DJ, Chen Y, Lee W. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 1996 ; 10 : 2794-2804. [Google Scholar]
  11. Classon M, Kennedy BK, Mulloy R, Harlow E. Opposing roles of pRb and p107 in adipocyte differentiation. Proc Natl Acad Sci USA 2000 ; 97 : 10826-10831. [CrossRef] [Google Scholar]
  12. Higgins C, Chatterjee S, Cherington V. The block of adipocyte differentiation by a C-terminally truncated, but not by full-length, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain. J Virol 1996 ; 70 : 745-752. [PubMed] [Google Scholar]
  13. Fajas L, Egler V, Reiter R, et al. The retinoblastoma-histone deacetylase 3 complex inhibits the peroxisome proliferator-activated receptor gamma and adipocyte differentiation. Dev Cell 2002 ; 3 : 903-910. [CrossRef] [PubMed] [Google Scholar]
  14. Sarruf DA, Iankova I, Abella A, et al. Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol 2005 ; 25 : 9985-9995. [CrossRef] [PubMed] [Google Scholar]
  15. Fu M, Rao M, Bouras T, et al. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem 2005 ; 280 : 16934-16941. [CrossRef] [PubMed] [Google Scholar]
  16. Aguilar V, Annicotte JS, Escote X, et al. Cyclin G2 regulates adipogenesis through PPAR gamma coactivation. Endocrinology 2010 ; 151 : 5247-5254. [CrossRef] [PubMed] [Google Scholar]
  17. Abella A, Dubus P, Malumbres M, et al. Cdk4 promotes adipogenesis through PPARgamma activation. Cell Metab 2005 ; 2 : 239-249. [CrossRef] [PubMed] [Google Scholar]
  18. Garriga J, Grana X. Cellular control of gene expression by T-type cyclin/CDK9 complexes. Gene 2004 ; 337 : 15-23. [CrossRef] [PubMed] [Google Scholar]
  19. Iankova I, Petersen RK, Annicotte JS, et al. PPAR{gamma} recruits the P-TEFb complex to activate transcription and promote adipogenesis. Mol Endocrinol 2006 ; 20 : 1494-1505. [CrossRef] [PubMed] [Google Scholar]
  20. Rane SG, Dubus P, Mettus RV, et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999 ; 22 : 44-52. [CrossRef] [PubMed] [Google Scholar]
  21. Tsutsui T, Hesabi B, Moons DS, et al. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol 1999 ; 19 : 7011-7019. [PubMed] [Google Scholar]
  22. Miyawaki K, Inoue H, Keshavarz P, et al. Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice. Diabetes Res Clin Pract 2008 ; 82 : 33-41. [CrossRef] [PubMed] [Google Scholar]
  23. Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 2004 ; 114 : 963-968. [PubMed] [Google Scholar]
  24. Fajas L, Annicotte JS, Miard S, et al. Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1#x2212;/− mice. J Clin Invest 2004 ; 113 : 1288-1295. [PubMed] [Google Scholar]
  25. Annicotte JS, Blanchet E, Chavey C, et al. The CDK4-pRb-E2F1 pathway controls insulin secretion. Nat Cell Biol 2009 ; 11 : 1017-1023. [CrossRef] [PubMed] [Google Scholar]
  26. Hansen JB, Jorgensen C, Petersen RK, et al. Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci USA 2004 ; 101 : 4112-4117. [CrossRef] [Google Scholar]
  27. Dali-Youcef N, Mataki C, Coste A, et al. Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc Natl Acad Sci USA 2007 ; 104 : 10703-10708. [CrossRef] [Google Scholar]
  28. Scime A, Grenier G, Huh MS, et al. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha. Cell Metab 2005 ; 2 : 283-295. [CrossRef] [PubMed] [Google Scholar]
  29. Goto Y, Hayashi R, Kang D, Yoshida K. Acute loss of transcription factor E2F1 induces mitochondrial biogenesis in HeLa cells. J Cell Physiol 2006 ; 209 : 923-934. [CrossRef] [PubMed] [Google Scholar]
  30. Sakamaki T, Casimiro MC, Ju X, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol 2006 ; 26 : 5449-5469. [CrossRef] [PubMed] [Google Scholar]
  31. Wang C, Li Z, Lu Y, et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci USA 2006 ; 103 : 11567-11572. [CrossRef] [Google Scholar]
  32. Scime A, Soleimani VD, Bentzinger CF, et al. Oxidative status of muscle is determined by p107 regulation of PGC-1 alpha. J Cell Biol 2010 ; 190 : 651-662. [CrossRef] [PubMed] [Google Scholar]
  33. Duran-Sandoval D, Thomas AC, Bailleul B, et al. Pharmacologie des agonistes de PPARα et PPARγ et des activateurs PPARα/γ mixtes en développement clinique. Med Sci (Paris) 2003 ; 19 : 819-825. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  34. Tiraby C, Langin D. PGC-1α, un co-activateur transcriptionnel impliqué dans le métabolisme. Med Sci (Paris) 2005 ; 21 : 49-54. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.